The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Tarriff Scott since year 2005.
The trader's CIK number is 1469124.
At the time of this reporting, Tarriff Scott is the CEO of Eagle Pharmaceuticals, Inc. .
(stock ticker symbol EGRX).
See this page for all insider trading activities at Eagle Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-06-28||EGRX||Eagle Pharmaceuticals, Inc.||Option Ex||124,804||4.04||504,208|
|2018-03-30||EGRX||Eagle Pharmaceuticals, Inc.||Option Ex||113,104||4.04||456,940|
|2016-04-01||EGRX||Eagle Pharmaceuticals, Inc.||Sale||30,765||40.63||1,249,981|
|2016-02-01||EGRX||Eagle Pharmaceuticals, Inc.||Sale||18,360||68.76||1,262,433|
|2016-01-04||EGRX||Eagle Pharmaceuticals, Inc.||Sale||14,549||86.33||1,256,087|
|2015-12-01||EGRX||Eagle Pharmaceuticals, Inc.||Sale||14,050||89.20||1,253,316|
|2015-11-02||EGRX||Eagle Pharmaceuticals, Inc.||Sale||19,339||64.78||1,252,877|
|2015-10-01||EGRX||Eagle Pharmaceuticals, Inc.||Sale||17,878||71.02||1,269,606|
|2015-09-01||EGRX||Eagle Pharmaceuticals, Inc.||Sale||16,245||76.50||1,242,823|
|2015-08-03||EGRX||Eagle Pharmaceuticals, Inc.||Sale||13,000||95.88||1,246,375|
|2015-07-01||EGRX||Eagle Pharmaceuticals, Inc.||Sale||15,710||79.58||1,250,280|
|2015-03-20||EGRX||Eagle Pharmaceuticals, Inc.||Sale||120,000||42.00||5,040,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tarriff Scott (CEO of Eagle Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.